Autopsy report · NCT01146561
Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 5 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 10 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Chronic Pancreatitis
- Interventions
- Tanezumab; Placebo
- Participants
- 2
- Sites
- 9
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.